Authors
Latest:
Artificial Intelligence: Beyond the glamorIt takes gritty work to make an AI application succeed—but it can be worth the effort
Latest:
Gaining Access to the European MarketDistributing products within the European market calls for focused knowledge of national practices
Latest:
The value of real-world data in drug commercializationUsing real-world databases for evidence development has strengths and weaknesses; with electronic health records (EHRs), new approaches are evolving
Latest:
Pharma is under-managing its multi-channel marketing effortsSurvey shows that most digital channels are still experiments with little oversight or follow-through
Latest:
Economic and clinical value: the future of cancer careAn 'expectations convergence' is building in how drug efficacy aligns with patient outcomes
Latest:
A Data-Driven Approach to Contract Performance Monitoring and AnalysisBetter use of available data can add rigor to analyzing managed-markets contracts, thereby allocating rebates / discounts more effectively
Latest:
Next-gen AI: Widespread adoption hinges on trustEmbracing AI 2.0 and modern machine learning as foundational tools to deepening HCP engagement
Latest:
A Process-Based Approach To Aggregate SpendA Process-Based Assessment (PBA) is the first step to analyzing reporting needs
Latest:
Reshaping Biotechnology's Financing Relay RaceThe current economic downturn may fuel the creation of new, more sustainable business models
Latest:
Three Areas to Drive Supply Chain ValueStrategic and proactive thinking are vital in providing supply chain leaders with an opportunity to shift their focus to a more holistic, value-centered approach.
Latest:
Optimizing the Patient Journey Through High-Touch, High-Tech Services for Innovative and Novel TherapiesDana Edwards shares strategies and best practices for developing and implementing high-tech, high-touch patient support programs for innovative and novel therapies to help connect patients to the services they need.
Latest:
Manufacturing at the Speed of AIHow pharma can harness digitalization all the way through commercialization
Latest:
Fostering Patient Engagement with PortalsSix engagement tips for companies to consider to improve patient use of portals
Latest:
How pharma and HCPs can support backlogged pandemic patientsFocusing on key groups will drive the greatest impact in health outcomes
Latest:
Adding Might to ‘Specialty Lite’Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market
Latest:
Why Reliable Pharma Shipping Outweighs CostAlthough companies are faced with constraints, regulations, and challenges in this space, the positives supersede the negatives.
Latest:
From Toggling Tediously Between Systems to Achieving Whole-Person CareThe rationale behind transforming case management in healthcare.
Latest:
The True Reliability of Real-World DataOutlining five questions that should be considered when assessing if RWD is “fit for purpose” in pharma research—and ultimately clinical and pharmacy decision support
Latest:
Harnessing the Potential of Data to Deliver the Future of HealthcareFaster approvals, more accurate and timely medicines monitoring—all enabled by harmonized, consistent and reliable data—will drive improved patient outcomes.
Latest:
Developing Your Roadmap to Pharma 4.0Questions to ask before transitioning into new technologies. By Yvonne Duckworth and Cory Perelman.
Latest:
Patient Centricity in the Pharma Supply ChainThe importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.
